ArticleOrphanet journal of rare diseases2026

Post-marketing safety signals of Wilson's disease therapies: evidence from FAERS and VigiBase.

Hülya Tezel-Yalçın et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.